Zimmer Biomet ZBH
$
Relative Strength Index (RSI)
- The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.
- The RSI is calculated using the following formula:
RSI = 100 - (100 / (1 + RS))
Where RS is the ratio of the average gains to the average losses over a specified period.
- The default time period used is 14 days.
- RSI values range between 0 and 100.
RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)
RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)
RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.
Key Insights
Zimmer Biomet (ZBH) Core Market Data and Business Metrics
Latest Closing Price
$112.5Price-Earnings Ratio
25.40Total Outstanding Shares
199.06 Million SharesDividend
$0.24 Per Share QuarterlySIC Description
Orthopedic, Prosthetic & Surgical Appliances & SuppliesPrimary Exchange
New York Stock ExchangeHeadquarters
345 East Main Street, Warsaw, IN, 46580
Historical Stock Splits
| Execution Date | Split Amount |
|---|---|
| No Historical Stock Splits | |
Short Interest
Track Short Interest Levels to Gauge Bearish Market Sentiment and Short Squeeze Potential
| Avg Daily Volume | Days to Cover | Settlement Date | Short Interest |
|---|---|---|---|
| 2,042,671 Shares | 3.05 | 3/14/2025 | 6,224,451 Shares |
| 1,866,473 Shares | 3.78 | 2/28/2025 | 7,051,367 Shares |
| 2,247,785 Shares | 3.15 | 2/14/2025 | 7,073,725 Shares |
| 1,763,775 Shares | 4.21 | 1/31/2025 | 7,422,836 Shares |
| 1,716,581 Shares | 4.45 | 1/15/2025 | 7,632,098 Shares |
| 1,716,584 Shares | 4.27 | 12/31/2024 | 7,336,497 Shares |
Cash Flow Statement
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Net Cash Flow From Financing Activities, Continuing | $-484.50 Million |
| Net Cash Flow From Operating Activities, Continuing | $1.50 Billion |
| Net Cash Flow From Investing Activities, Discontinued | $0 |
| Net Cash Flow, Continuing | $126.80 Million |
| Net Cash Flow From Operating Activities, Discontinued | $0 |
| Net Cash Flow, Discontinued | $0 |
Income Statement
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Income Tax Expense/Benefit | $131.40 Million |
| Interest Income/Expense Operating, Net | $-218 Million |
| Operating Income/Loss | $1.29 Billion |
| Income/Loss From Continuing Operations After Tax | $905.20 Million |
| Other Operating Expenses | $275.60 Million |
| Income/Loss From Discontinued Operations Net Of Tax | $0 |
Comprehensive Income
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Comprehensive Income/Loss Attributable To Parent | $832 Million |
| Other Comprehensive Income/Loss Attributable To Parent | $-71.80 Million |
| Comprehensive Income/Loss | $832 Million |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0 |
| Other Comprehensive Income/Loss | $-71.80 Million |
Balance Sheet
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Equity Attributable To Parent | $12.47 Billion |
| Current Assets | $4.67 Billion |
| Assets | $21.37 Billion |
| Noncurrent Liabilities | $6.44 Billion |
| Equity | $12.48 Billion |
| Noncurrent Assets | $16.69 Billion |
Historical Dividends
Current dividend: $0.24 Per Share Quarterly
| Announcement Date | Payment Date | Record Date | Amount | Frequency |
|---|---|---|---|---|
| Feb 26, 2025 | Apr 30, 2025 | Mar 31, 2025 | $0.24 | Quarterly |
| Dec 18, 2024 | Jan 31, 2025 | Dec 30, 2024 | $0.24 | Quarterly |
| Aug 29, 2024 | Oct 31, 2024 | Sep 30, 2024 | $0.24 | Quarterly |
| May 13, 2024 | Jul 31, 2024 | Jun 26, 2024 | $0.24 | Quarterly |
| Feb 21, 2024 | Apr 30, 2024 | Mar 29, 2024 | $0.24 | Quarterly |
| Dec 14, 2023 | Jan 31, 2024 | Dec 27, 2023 | $0.24 | Quarterly |